Effects of Short-Term Exercise Training on Plasminogen Activator Inhibitor (PAI-1)

Medicine and Science in Sports and Exercise

Volumn 35, Issue 11, 2003, Pages 1853-1858

  Bodary, Peter F ^a,b   Yasuda, Norie ^a   Watson, Deidre D ^a   Brown, Adrienne S ^a   Davis, J Mark ^a   Pate, Russell R ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cardiovascular disease; Fibrinolysis; Hemostasis; Physical activity; Sedentary

Indexed keywords

FIBRINOGEN; GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEART RATE; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLISM; MOTOR ACTIVITY; OBESITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SHORT COURSE THERAPY; SHORT TERM EXERCISE TRAINING; SITTING; TRAINING; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; TYPES OF STUDY;

AGED; BODY MASS INDEX; EXERCISE; FEMALE; FIBRINOGEN; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PLASMINOGEN INACTIVATORS;

EID: 0242442120     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000093751.82616.F0     Document Type: Article

References (27)

1. ABBASI, F., T. MCLAUGHLLN, C. LAMENDOLA, I. LIPINSKA, G. TOFLER, and G. M. REAVEN. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women. Arterioscler. Thromb. Vasc. Biol. 19:2818-2821, 1999.
2. ANGELOPOULOS, T. J., R. LEWIS, T. JAMURTAS, and C. SCHUMANN. Significant changes in VLDL-triacylglycerol and glucose tolerance in obese subjects following ten days of training. Eur. J. Appl. Physiol. 77:556-559, 1998.
3. BLAIR, S. N., H. W. KOHL III, C. E. BARLOW, R. S. PAFFENBARGER, Jr., L. W. GIBBONS, and C. A. MACERA. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 273:1093-1098, 1995.
4. BROWN, M. D., G. E. MOORE, M. T. KORYTKOWSKI, S. D. MCCOLE, and J. M. HAGBERG. Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women. Hypertension 30:1549-1553, 1997.
5. BYBERG, L., A. SIEGBAHN, L. BERGLUND, P. MCKEIGUE, R. RENELAND, and H. LITHELL. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler. Thromb. Vasc. Biol. 18:258-264, 1998.
6. CALLES-ESCANDON, J., S. A. MIRZA, B. E. SOBEL, and D. J. SCHNEIDER. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47:290-293, 1998.
7. DILL, D. B., and D. L. COSTILL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37:247-248, 1974.
8. EITZMAN, D. T., R. J. WESTRICK, E. G. NABEL, and D. GINSBURG. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95:577-580, 2000.
9. HITTEL, D. S., W. E. KRAUS, and E. P. HOFFMAN. Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome. J. Physiol. 548:401-410, 2003.
10. HOUMARD, J. A., J. H. COX, P. S. MACLEAN, and H. A. BARAKAT. Effect of short-term exercise training on leptin and insulin action. Metabolism 49:858-861, 2000.
11. JACKSON, A. S., and M. L. POLLOCK. Generalized equations for predicting body density of men. Br. J. Nutr. 40:497-504, 1978.
12. JACKSON, A. S., M. L. POLLOCK, and A. WARD. Generalized equations for predicting body density of women. Med. Sci. Sports Exerc. 12:175-181, 1980.
13. JANAND-DELENNE, B., C. CHAGNAUD, D. RACCAH, M. C. ALESSI, I. JUHAN-VAGUE, and P. VAGUE. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int. J. Obes. Relat. Metab. Disord. 22:312-317, 1998.
14. KIM, E., and M. GOLDBERG. Serum cholesterol assay using a stable Liebermann-Burchard reagent. Clin. Chem. 15:1171-1179, 1969.
15. LINDAHL, B., T. K. NILSSON, K. ASPLUND, and G. HALLMANS. Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism 47:384-390, 1998.
16. LINDAHL, B., T. K. NILSSON, J. H. JANSSON, K. ASPLUND, and G. HALLMANS. Improved fibrinolysis by intense lifestyle intervention: a randomized trial in subjects with impaired glucose tolerance. J. Intern. Med. 246:105-112, 1999.
17. MAVRI, A., M. C. ALESSI, D. BASTELICA, et al. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia 44:2025-2031, 2001.
18. MAVRI, A., M. STEGNAR, M. KREBS, J. T. SENTOCNIK, M. GEIGER, and B. R. BINDER. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler. Thromb. Vasc. Biol. 19:1582-1587, 1999.
19. RAURAMAA, R., and S. B. VAISANEN. Physical activity in the prevention and treatment of a thrombogenic profile in the obese: current evidence and research issues. Med. Sci. Sports Exerc. 31:S631-S634, 1999.
20. SCHUIT, A. J., E. G. SCHOUTEN, C. KLUFT, M. DE MAAT, P. P. MENHEERE, and F. J. KOK. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb. Haemost. 78:845-851, 1997.
21. SIRI, W. E. Body composition from fluid spaces and density: analysis of methods in techniques for measuring body composition. Washington, DC: National Research Council, National Academy of Sciences, 1961, pp. 223-244.
22. SMITH, D. T., G. L. HOETZER, J. J. GREINER, B. L. STAUFFER, and C. A. DESOUZA. Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J. Physiol. 546:289-298, 2003.
23. SVENDSEN, O. L., C. HASSAGER, C. CHRISTIANSEN, J. D. NIELSEN, and K. WINTHER. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 16:381-385, 1996.
24. SZYMANSKI, L. M., R. R. PATE, and J. L. DURSTINE. Effects of maximal exercise and venous occlusion on fibrinolytic activity in physically active and inactive men. J. Appl. Physiol. 77:2305-2310, 1994.
25. THOGERSEN, A. M., J. H. JANSSON, K. BOMAN, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98:2241-2247, 1998.
26. WANNAMETHEE, S. G., G. D. LOWE, P. H. WHINCUP, A. RUMLEY, M. WALKER, and L. LENNON. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105:1785-1790, 2002.
27. WARNICK, G. R., J. BENDERSON, and J. J. ALBERS. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28:1379-1388, 1982.